NCT03569072View on ClinicalTrials.gov

High Intensity Functional Image Guided Vmat Lung Evasion

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

January 27, 2021

Study Completion Date

January 27, 2021

Conditions
Non Small Cell Lung Cancer Stage III
Interventions
RADIATION

Functionally adapted, dose escalated VMAT radiotherapy

Volumetric Modulated Arc Therapy planning and treatment delivery to treat primary and nodal planning target volume with 60 Gy in 30 fractions and a simultaneous integrated boost to the primary tumour to a total dose 69Gy in 30 fractions while avoiding organs at risk including functional lung, heart and oesophagus.

Trial Locations (1)

3000

Peter MacCallum Cancer Centre, Melbourne

All Listed Sponsors
lead

Peter MacCallum Cancer Centre, Australia

OTHER

NCT03569072 - High Intensity Functional Image Guided Vmat Lung Evasion | Biotech Hunter | Biotech Hunter